On February 2, 2021, Mateon Therapeutics, Inc. (OTC:MATN) announced that the ARTI-19 trial of ARTIVedaâ„¢/PulmoHealâ„¢ against COVID-19 in India has completed ...
On November 30, 2020, Mateon Therapeutics, Inc. (OTC:MATN) provided a development update on ARTIVeda™/ArtiShield™, the company’s lead Ayurvedic drug against ...
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback